Moreover, TELO2 immunostain score was significant higher in low-grade gliomas than in normal brain (P = 1.54×10−4, P adjusted by Bonferroni method, Figure 6K), supporting TELO2 protein overexpressed in high-grade gliomas in comparison with normal brain tissue control. Here, TELO2 is linked to central nervous system cancer.